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Aim. +e aim of this systematic review was to analyze and synthesize available evidence for the effects of somatic acupoint
stimulation (SAS) on cancer-related sleep disturbance in adults with cancer. Methods. Nine databases and four clinical trial
registries were searched from their inception to July 2019 to identify potential articles and registered trials. Two authors in-
dependently extracted data and appraised the methodological quality of the included studies. +e included studies could not be
subjected to meta-analysis due to the significant variations in SAS intervention protocols and outcomemeasurement instruments.
+is systematic review therefore reported the results of the included trials narratively. Results. Seven studies were identified, which
involved 906 cancer patients. SAS protocols varied across trials without an optimal evidence-based standard intervention protocol
to manage cancer-related sleep disturbance. Sanyinjiao (SP6) was the most commonly selected acupoint. Manual acupuncture was
typically 15–30min in duration and was conducted once a day or once a week for a period of 1–5 weeks, whereas self-administered
acupressure was typically 1–3min in duration per point and was conducted once a day, such as during night time before going to
bed, for a period of 1–5 months. +e results indicated that SAS could potentially relieve cancer-related sleep disturbance and
improve quality of life. Mild adverse effects were reported in three of the included studies, but none of them performed a causality
analysis to clarify the association between the reported adverse events and the intervention. Conclusions. +is systematic review
showed that SAS is a useful approach to relieving cancer-related sleep disturbance. However, research evidence on SAS for
managing cancer-related sleep disturbance has not been fully conclusive due to the limited number of existing clinical studies with
relatively small sample size and suboptimal methodological quality. Clinical trials with large sample size and robust methodology
are warranted in future research.
1. Introduction
Sleep disturbance is one of the most frequently reported
symptoms experienced by individuals affected by cancer,
with a prevalence ranging from 14% to 93% [1–3]. Cancer-
related sleep disturbance is manifested as early morning
awakening, trouble falling asleep, and difficulty staying
asleep [4]. Cancer-related symptoms, such as anxiety, de-
pression, fatigue, and pain, tend to be exacerbated by sleep
disturbance [5]. Sleep disturbance can cause significant
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psychological distress in patients with cancer [6]. Sleep
disturbance also appreciably impairs the functional status
and quality of life (QoL) of patients with cancer [7]. Cancer-
related sleep disturbance has become an important health
issue, which can impair patient outcomes; however, this
problem has not yet been adequately addressed in health
care settings [8].
Somatic acupoint stimulation (SAS) is a broad term
that describes body acupoint stimulation methods, with
manual acupuncture and acupressure, to balance the ex-
cess or deficiency of Qi on the basis of traditional Chinese
medicine (TCM) theory [9]. Manual acupuncture entails
needle insertion into the body at specific acupoints,
whereas manual acupressure refers to the stimulation of
acupoints by applying pressure using the fingers or thumbs
[10]. Multiple systematic reviews reported that SAS is a
safe and effective therapy in managing sleep disturbance in
noncancerous populations [11–15]. Patients with cancer
would also prefer SAS to manage sleep disturbance given
that this approach elicits fewer side effects than other
pharmacological treatment options [15, 16]. However,
effects of SAS on cancer-related sleep disturbance have not
been fully conclusive in current clinical pracrtice and
research.
Clinical studies have examined the effects of SAS on cancer-
related sleep disturbance with contradictory findings reported
[17–22]. Several small scale clinical trials (sample size ranged
from 10 to 94) reported that SAS can alleviate sleep disturbance
in patients with cancer [18–21], whereas another three-arm
clinical trial with 288 cancer patients showed no significant
differences among the effects of relaxing acupressure, stimu-
lating acupressure, and control treatment on the sleep quality of
patients with cancer at week 10; only the relaxing acupressure
group reported significantly better sleep quality than the control
group at week 6 [22].
One recent systematic review that evaluated the effects of
acupuncture on insomnia in patients with cancer showed
that acupuncture might be superior to conventional med-
ications and sham acupuncture for managing cancer-related
sleep disturbance [23]. However, this review excluded
acupressure as one of the most important and commonly
practised modalities of SAS, and included a small number of
clinical trials with limited sample size [23], all of which
contributed to inconclusive evidence on SAS for managing
cancer-related sleep disturbance. Currently, researchers
have not reached consensus on the optimal acupoint for-
mula or intervention dosage to apply SAS to manage cancer-
related sleep disturbance [19, 22]. Whether the existing
evidence is scientifically rigorous enough to support the use
of SAS for cancer-related sleep disturbance management
remains unclear.
+is systematic review was therefore designed to further
explore the role and safety of SAS, including both body
acupuncture and body acupressure, for the alleviation of
cancer-related sleep disturbance. Specifically, this review
explored (1) the best available evidence for the effects of SAS
on cancer-related sleep disturbance; (2) the commonly used
SAS intervention protocols to manage cancer-related sleep
disturbance; (3) the commonly utilized research instruments
to assess cancer-related sleep quality; and (4) the safety and
cost-effectiveness of using SAS for managing sleep distur-
bance in patients with cancer.
2. Methods
2.1. Study Selection. +e Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) checklist
[24] was used in determining the content required and
systematic process for this systematic review.+e protocol of
this systematic review has been registered at PROSPERO
(no. CRD42019131609).
Nine databases were searched from their inception to
July 2019 for the identification of potential articles and
registered trials published in English and Chinese. +e
databases were Allied and Complementary Medicine,
Cochrane Central Register of Controlled Trials, Cumulative
Index to Nursing and Allied Health Literature, Excerpta
Medica Database, PsycINFO, PubMed, Web of Sciences,
Chinese Medical Literature Database, and Wanfang Data-
base.+e following trial registeries for ongoing or completed
trials were also searched: World Health Organization In-
ternational Clinical Trials Registry Platform (https://www.
who.int/ictrp/trial_reg/en/), ClinicalTrials.gov (https://
clinicaltrials.gov/), National Research Register via the De-
partment of Health, UK (http://www.dh.gov.uk), and the
Australian New Zealand Clinical Trials Registry (http://
www.anzctr.org.au/).
+e search strategy examples are presented in Table 1
and the following MESH terms and keywords were used in
developing electronic search strategies: English:
“acupunctur∗”, “acupressur∗”, “acupoint∗”, “massag∗”
“sleep”, “insomnia”, “neoplasms”, “tumour”, “cancer”,
“malignan∗” “carcinoma∗”, and “oncolog∗”. Chinese: “针∗”,
“穴位∗”, “睡眠障碍”, “失眠”, “睡眠”, “肿瘤”, and “癌症”.
+is systematic review developed an individualized search
strategy for each database and screened all the reference lists
of previous reviews and included studies for additional
relevant articles.
Two authors (X.L. Liu and H.L. Cheng) independently
assessed the titles and abstracts of all records identified
through the broad initial search. All duplicated records were
managed and subsequently excluded using EndNote X9. If
the detailed information from the titles and abstract was
unclear to the reviewers, the full text of the publications was
retrieved. +e final decision to include or exclude a trial was
based on an assessment of the full texts of all retrieved
publications and registered trials. Any disagreements during
these processes were settled by discussion with a third author
if necessary. An assessment Excel form detailing specific
reasons for the exclusion of publications was developed.
2.2. Inclusion Criteria
(1) Types of Study. Randomized controlled trials (RCTs). (2)
Participants. Adult patients with cancer reporting sleep
disturbance regardless of types or stages of cancer or pre-
vious cancer treatments. (3) Intervention(s). SAS: manual
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Table 1: Searching strategy examples.
Items Searching strategy example
PubMed
#1 (((acupuncture[MeSH terms]) OR acupuncture therapy[MeSH terms]) OR acupuncture points[MeSH terms]) OR acupressure[MeSH terms]
#2 ((((acupunctur
∗[Title/Abstract]) OR acupoin∗[Title/Abstract]) OR acupressur∗[Title/Abstract]) OR massag∗[Title/Abstract]) OR
plaster∗[Title/Abstract]
#3 #1 OR #2
#4 (“neoplasms”[MeSH terms]) OR “cancer survivors”[MeSH terms]
#5 ((((((neoplasm
∗[Title/Abstract]) OR tumor∗[Title/Abstract]) OR tumour∗[Title/Abstract]) OR cancer∗[Title/Abstract]) OR
malignan∗[Title/Abstract]) OR carcinoma∗[Title/Abstract]) OR oncolog∗[Title/Abstract]
#6 #4 OR #5
#7 ((“sleep initiation and maintenance disorders”[MeSH terms])) OR “sleep wake disorders”[MeSH terms]
#8 (((Sleep
∗[Title/Abstract]) OR insomnia“[Title/Abstract]) OR sleep disturbance∗[Title/Abstract]) OR sleep disorder∗[Title/
Abstract]
#9 #7 OR #8
#10 #6 AND #9
#11 #3 AND #10
#12
(((((((((“randomized controlled trial”[Publication Type]) OR “controlled clinical trial”[Publication Type]) OR “ramdomized”[Title/
Abstract]) OR “ramdomised”[Title/Abstract]) OR “placebo”[Title/Abstract]) OR “sham”[Title/Abstract]) OR “randomly”[Title/
Abstract]) OR “trial”[Title/Abstract]) OR “groups”[Title/Abstract])
#13 #11 AND #12
#14 (animals[MeSH terms] NOT (humans[MeSH terms] AND animals[MeSH terms]))
#15 #13 NOT #14
Cochrane Central Register of Controlled Trials (CENTRAL)
#1 MeSH descriptor: [acupuncture] explode all trees
#2 MeSH descriptor: [acupuncture therapy] explode all trees
#3 MeSH descriptor: [acupuncture points] explode all trees
#4 MeSH descriptor: [acupressure] explode all trees
#5 “acupunctur
∗”:ti,ab, kw or acupoin∗:ti,ab, kw or acupressur∗:kw or massag∗:ti,ab, kw or plaster∗:ti,ab, kw (word variations have
been searched)
#6 #1 or #2 or #3 or #4 or #5
#7 MeSH descriptor: [neoplasms] explode all trees
#8 MeSH descriptor: [cancer survivors] explode all trees
#9 neoplasm
∗:ti,ab, kw or tumor∗:ti,ab, kw or tumour∗:ti,ab, kw or cancer∗:ti,ab, kw or malignan∗:ti,ab, kw or carcinoma∗:ti,ab, kw or
oncolog∗:ti,ab, kw (word variations have been searched)
#10 #7 or #8 or #9
#11 #6 and #10
#12 MeSH descriptor: [sleep initiation and maintenance disorders] explode all trees
#13 MeSH descriptor: [sleep-wake disorders] explode all trees
#14 Sleep
∗:ti,ab, kw or insomnia:ti,ab, kw or sleep disturbance∗:ti,ab, kw or sleep disorder∗:ti,ab, kw (word variations have been
searched)
#15 #12 or #13 or #14
#16 #11 and #15
#17 Trials + Cochrane protocol
Embase Classic + Embase
#1 Acupuncture∗.m_titl.
#2 Acupressur∗.m_titl.
#3 acupoin∗.m_titl.
#4 massag∗.m_titl.
#5 #1 or #2 or #3 or #4
#6 Neoplasm∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#7 “tumor∗”.m_titl.
#8 “tumour∗”.m_titl.
#9 cancer∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#10 malignan∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#11 carcinoma∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#12 oncolog∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#13 #6 or #7 or #8 or #9 or #10 or #11 or #12
#14 #5 and #13
#15 Sleep∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#16 Insomnia∗.mp. [mp� ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
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acupuncture or manual acupressure on the specific body
acupoints as interventions performed or taught by acu-
puncture practitioners, Chinese medicine practitioners,
nurses, or other health care professionals. All forms of
auricular acupoint stimulation, electronic acupoint stim-
ulation, point injection, and transcutaneous electrical nerve
stimulation were excluded. (4) Control. Routine methods of
treatment for cancer-related sleep disturbance, sham
(placebo) SAS, or usual care. (5) Primary Outcomes. (a).
Cancer-related sleep disturbance and sleep quality mea-
sured by any validated tool and (b). self-reported hours of
sleep and sleep efficiency, determined by the ratio of the
total sleep time to the time spent in bed. (6) Secondary
Outcomes. (a). QoL; (b). satisfaction with SAS; (c). safety of
SAS, including any adverse events of SAS, such as dizziness
and local bleeding, and the number of participants drop-
ping out due to adverse events; and (d). cost-effectiveness
of SAS.
2.3. Data Extraction. Two reviewers (X.L. Liu and H.L.
Cheng) worked independently to extract the data of the
included studies by using a predefined data extraction
form. +e research designs, study settings, patient de-
mographics, SAS protocols (including the acupoint for-
mula, intervention session, intervention duration and
frequency), comparisons, and outcomes were extracted. If
some data of the included studies were missing or unclear,
the reviewers contacted the original authors of the in-
cluded studies to seek clarification.
2.4. Methodological Quality and Risk of Bias Assessment.
+e risk of bias assessment tool, developed by the Cochrane
Back Review Group, was applied to assess the methodo-
logical quality and risk of bias of the included studies as
“high”, “low”, “unclear”, or “not applicable”. +e tool
comprises a set of specific questions related to randomi-
zation and concealment of intervention allocation; partici-
pant, health care provider, and outcome assessor blinding;
cointervention avoidance; compliance; dropout rate; out-
come assessment timing; selective reporting; and group
similarity [25]. Two reviewers (X.L. Liu and H.L. Cheng)
independently assessed the methodological quality and risk
of bias of the included RCTs. Further details were identified
by contacting the primary authors if the data were un-
available in the relevant reports. Any discrepancies between
the reviewers were reconciled through discussion or con-
sultation with a third reviewer.
2.5. Strategies for Data Synthesis. Only descriptive analysis,
rather than meta-analysis, was conducted in this systematic
review because of the considerable clinical heterogeneity
identified in the SAS protocols, intervention dosages, time
points of data collections, and measures of study outcomes.
Meta-analysis has been deemed inappropriate for use in
systematic reviews with substantial clinical heterogeneity of
the included studies [26]. Clinical heterogeneity generally
refers to variability in the study participants, intervention
characteristics, and types or time points of outcome as-
sessment [27]. In meta-analysis, credibility of the quanti-
tative synthesis findings can be significantly affected by the
clinical heterogeneity of the analyzed studies, often skewing
the conclusions [27, 28]. Funnel plot and Egger’s bias test
were not performed to gauge potential publication bias in
this systematic review given that only seven trials were
included.
3. Results
3.1. Selectionof Studies. Figure 1 illustrates the PRISMA flow
diagram of information through the review. +is diagram
specifies the number of records identified at each stage and
the reasons that records were removed.+e title and abstract
of 495 potential records were reviewed. Following the in-
clusion and exclusion criteria, 40 abstracts appeared relevant
to the research questions were considered suitable for fur-
ther evaluation of their full-texts. +en, 33 articles were
rejected at this stage because they did not meet the eligibility
criteria. +us, seven studies, including five published studies
[19, 21, 22, 29, 30], and two registered ongoing or completed
trials [31, 32], were finally included in this systematic review.
3.2. Characteristics of the Included Trials. Table 2 provides a
summary of the seven studies included in this systematic
review. +e included studies comprised 906 randomized
cancer patients. Only published articles (n = 5) reported
the number of patients who completed the intervention.
+e average sample size of the included trials was 129
(range: 57–288). Six published studies or registered trials
were published in English [19, 21, 22, 30–32], and only
one study was published in Chinese [29]. +e included
trials were conducted in Mainland China [21, 29], the
United States [22, 31], Denmark [19], Taiwan [30], and
Vietnam [32].
+ree studies comprised two arms [21, 29, 31], and the
other studies comprised three arms. For control groups,
placebo (sham) group was used in four trials [19, 30–32].
Four studies targeted a single cancer type, such as lung
Table 1: Continued.
Items Searching strategy example
#17 sleep disturbance∗.m_titl.
#18 sleep disorder∗.m_titl.
#19 #15 or #16 or #17 or #18
#20 #14 and #19
Wanfang Database
题名或关键词: ((“针灸” + “穴位按压” + “穴位按摩” + “穴位”) ∗ (“失眠” + “睡眠障碍” + “睡眠”) ∗ (“癌症” + “肿瘤”+ “癌性”))
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Records identified through
database searching
(n = 492: English 449, Chinese 43)
Additional records identified
through other sources
(n = 3) 
Records aer 54 duplicates removed
(n = 441)
Records screened for
title and/or abstract
(n = 441) 
Removal based on exclusion
criteria (n = 401) 
Full-text articles assessed for
eligibility
(n = 40, including two registered
ongoing/completed studies) 
Full-text articles excluded
(n = 33)
Inconsistent population (n = 4)
Inconsistent intervention (n = 15)
Inconsistent study type (n = 8)
Conference abstract (n = 6)
Studies included
(n = 7)
Id
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Figure 1: PRISMA flow diagram for search results.
Table 2: Characteristics of RCTs examining somatic acupoint stimulation included in systematic review.
First author,
year, setting Study design Participants (n) SAS type
Intervention
Follow-up
Sleep-
related
outcomesIntervention group(s)
Sham/control
group(s)
H.T. Hoang,
2019,
Vietnam [32]
Randomized
controlled
trial
(registered
ongoing/
completed
study)
Randomized� 114,
38 patients in each
group
Self-
administered
acupressure
Self-acupressure group:
standard care and true self-
acupressure intervention
protocol
Placebo
comparator
group:
enhanced
standard
care + sham
self-
acupressure
No
intervention
group:
enhanced
standard care
Weekly
phone call
follow-up
(during the
four-week
intervention)
ISI and
sleep
parameter
in sleep
diary
S.M. Zick,
2016, USA
[22]
Randomized
controlled
trial
(published
study)
Randomized� 288
Completed� 228
Relaxing
acupressure group:
74 (completed)
Stimulating
acupressure group:
70 (completed)
Usual care group:
84 (completed)
Self-
administered
acupressure
Relaxing acupressure
(intervention 1), stimulating
acupressure (intervention 2)
Usual care 4-weekfollow-up PSQI
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cancer [30] or breast cancer [19, 22, 31], whereas three
studies recruited patients with different types of cancer
[21, 29, 32]. +e average age of participants in the in-
cluded trials was above 50 years old [19, 22, 29, 30]. +ree
studies recruited only female patients with cancer
[19, 22, 31].
+e commonly utilized research instruments to assess
cancer-related sleep was the Pittsburgh Sleep Quality
Index (PSQI), which was used in four trials [21, 22, 29, 30].
Two types of assessment instruments were used to assess
sleep disturbance and sleep quality in the included studies.
+e first type of instrument comprises qualitative
assessment tools, such as sleep diaries, which were used to
evaluate total sleep time (min), total time in bed (min), the
number of night awakenings after sleep onset, and sleep
efficiency [32]. +e other type includes self-reported in-
struments, such as the Athens Insomnia Scale (AIS), the
Insomnia Severity Index (ISI), and the PSQI
[21, 22, 29, 30], which were used to quantify patients' sleep
quality.
3.3. Somatic Acupoint Stimulation Protocols. Two types of
SAS protocols were used in the included trials: (1) self-
Table 2: Continued.
First author,
year, setting Study design Participants (n) SAS type
Intervention
Follow-up
Sleep-
related
outcomesIntervention group(s)
Sham/control
group(s)
Y.L. Zhao,
2015, China
[29]
Randomized
controlled
study
(published
study, thesis)
Randomized� 208
Completed� 190
Intervention group:
93 (completed)
Control drug
group: 97
(completed)
Acupuncture
(including
moxibustion
as an
additional
treatment)
Acupuncture +moxibustion Control drug:estazolam
7-day follow-
up
AIS and
PSQI
W.R. Tan,
2014, Taiwan
[30]
Experimental
pilot study,
randomized
controlled
study
(published
study
Randomized� 57
Completed� 45
Acupressure/oils
group: 15
(completed)
Acupressure only
group: 16
(completed)
Control group: 14
(completed)
Self-
administered
acupressure
Acupressure + oils group:
acupressure with 5%
essential oil; acupressure
includes kneading, pointing,
pressing, and pushing.
Acupressure only group:
includes kneading, pointing,
pressing, and pushing.
Sham
acupressure NR PSQI
S. Bokmand,
2013,
Denmark
[19]
Randomized
controlled
trial
(published
study)
Randomized� 94
Completed� 94
Intervention group:
31 (completed)
Sham group: 29
(completed)
No-treatment
group: 34
(completed)
Manual
acupuncture
Manual acupuncture in the
selected acupuncture points
Sham group:
manual
acupuncture
in the selected
sham points.
No-treatment
group:
received no
acupuncture.
NR
Disturbed
night sleep
(rated as
“yes” or
“no”)
Y. Feng, 2011,
China [21]
Randomized
controlled
trial
(published
study)
Randomized� 80
Completed� 80
Intervention group:
40 (completed)
Control group: 40
(completed)
Manual
acupuncture
Manual acupuncture on the
acupoints
Standard care
with
fluoxetine
hydrochloride
NR PSQI
S. David,
2010, USA
[31]
Randomized
controlled
trial
(registered
ongoing/
completed
study)
Randomized� 65; Acupuncture Acupuncture
A validated
sham
acupuncture
control
One month
following the
completion
of
intervention
and six
months after
the
conclusion
of
intervention
Insomnia
reduction
SAS: somatic acupoint stimulation; ISI: Insomnia Severity Index; PSQI: +e Pittsburgh Sleep Quality Index; AIS: Athens insomnia scale; NR: not reported.
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administered acupressure [22, 30, 32] and (2) manual needle
acupuncture [19, 21, 29, 31]. In one needle acupuncture
study, moxibustion was additionally used on two points:
Shenque (CV8) and Guangyuan (CV4) [29]. Sanyinjiao
(SP6) was used in five trials [19, 21, 22, 29, 30]. Yintang (EX-
HN3) and Baihui (DU/GV20) were used in four; Shenmen
(HT7), Zusanli (ST36), Taichong (LR3), and Neiguan (PC6)
were used in three; and Taixi (KI3) andHegu (LI4) were used
in two. One registered trial did not report the selected
acupoints [31].
For the duration of SAS, manual acupuncture was
typically 15–30min in duration and was conducted once a
day or once a week for a period of 1–5 weeks, whereas self-
administered acupressure was typically 1–3min in duration
per point and was conducted once a day, such as during
night time before going to bed, from 1 to 5 months. For
manual acupuncture, the depth of needle insertion was
0.5–1.5 cun [29]. Participants' self-acupressure skills re-
garding acupoint location, acupressure intensity, and
stimulation techniques were taught by nurses who were
trained by the main researcher and a TCM professional (the
intervention protocol had been validated by six Chinese
medicine experts) [32], by acupressure educators who were
trained by the study investigator [acupuncturist] [22], or by
research assistants (RAs) who were trained by qualified
TCM practitioners [30]. One study used acupressure with oil
as an intervention [30].
+e full details of the SAS protocols used in the included
studies are presented in Table 3.
3.4. Methodological Quality and Risk of Bias of the Included
Trials. Table 4 presents the methodological quality and risk
of bias summary of each included trial. Randomization was
mentioned in all seven RCTs, and six of which provided the
precise descriptions of the processes used to generate ran-
dom sequences. Adequate allocation concealmentwas de-
scribed in four RCTs (low risk of bias). Only five RCTs
reported a blind design for the participants and outcome
assessor (low risk of bias).
Common methodological issues identified across these
trials included limited information on the method of ran-
domization, allocation concealment, cointerventions, and
study results. For example, limited information was used in
the assessment of the methodological quality of two regis-
tered studies because the full-text publications of these two
trials could not be found or have not been published yet
[31, 32]. Five items were not applicable to the two registered
studies [31, 32]. Only three published trials mentioned and
used intention-to-treat analysis [22, 29, 30]. Funnel plot
analysis was not feasible because of the scarcity of trials in
this systematic review.
3.5. Descriptive Analysis of Outcomes. +e included studies
could not be subjected to meta-analysis due to the significant
variations in SAS intervention protocols and outcome
measurement instruments. +us, this systematic review
reported results from these included trials narratively.
3.5.1. Pittsburgh Sleep Quality Index. Four of the included
trials reported PSQI scores [21, 22, 29, 30]. Two studies
reported a significant between-group difference in PSQI
scores at the end of the study [21, 29]. In a three-arm RCT,
Tang et al. reported that PSQI scores in the acupuncture with
oil and acupuncture-only groups reduced compared with
that in the control group [30].+e adjusted PSQI score in the
acupressure with oil group changed significantly compared
with that in the control group at day one of the third
chemotherapy cycle [30]. +e change in the mean PSQI
score of the acupressure-only group was not as pronounced
as that of the control group at day one of the sixth che-
motherapy cycle [30].
Another three-arm trial reported an improvement in the
PSQI scores in the two intervention groups—relaxing
acupressure and stimulating acupressure—when compared
with the control group but the difference did not reach
statistical significance [22]. +is study [22] reported that the
PSQI scores at week six in the relaxing acupressure group
were significantly lower than PSQI scores in the control
treatment but were not significantly different from that in
the stimulating acupressure group. At week 10, no signifi-
cant difference between the three arms was observed [22].
3.5.2. Disturbed Night Sleep. Only one of the included
studies with a three-arm design used disturbed night sleep
(rated as “yes” or “no”) as a sleep quality index [19]. After 5
weeks of acupuncture intervention, the disturbed night sleep
of patients with breast cancer receiving acupuncture treat-
ment showed a statistically significant improvement com-
pared with those receiving sham acupuncture or no
treatment [19]. +e intervention effects on disturbed night
sleep lasted for at least 12 weeks after the final acupuncture
session [19].
3.5.3. Athens Insomnia Scale. Only one of the included
studies used the AIS to assess patients’ baseline condition but
did not report the post-intervention AIS data [29].
3.5.4. Insomnia Severity Index, Sleep Parameter in Sleep
Diary and Insomnia Reduction. Two ongoing or completed
registered trials used the ISI [31, 32], and one utilized the
sleep parameter [32].
3.5.5. Quality of Life (QoL). Two of the included trials re-
ported data on QoL, which were measured by the Long-
Term Quality of Life Instrument (LTQL) [22] and MOS-
SF36 [26]. In a three-arm RCT, Zick et al. reported that, at
week 6 and week 10, three of the four QoL subscales, in-
cluding somatic, fitness, and social support, improved more
in the relaxing acupressure group than the control group
[22]. No significant improvement in QoL scores between the
stimulating acupressure group and the control group for any
subscale at either time point was observed [22]. Zhao's study
[29] did not find any significant difference in QoL scores
between the intervention and control groups.
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Table 3: Somatic acupoint stimulation protocols used in the included studies.
First author,
year, country SAS type
SAS protocols
Selected acupoints: no. and names Responseselicited Instructions of SAS
Total
sessions
H.T. Hoang,
2019, Vietnam
[32]
Self-acupressure
6: Baihui (DU/GV 20), Yintang
(EX-HN3), Fengchi (GB20),
Neiguan (PC6), Shenmen (HT7),
and Taichong (LR3)
NR
Daily acupressure at night with
stimulation for each acupoint
lasting 3 minutes, 24 minutes in
total.
Participants received a weekly
phone call follow-up
from the study investigator to
remind them to self-practice
acupressure at home. Training:
participants
received a self-acupressure training
section at hospital from four trained
nurses.
4 weeks (28
days, 28
sessions)
S.M. Zick,
2016, USA
[22]
Self-administered
acupressure
Relaxing acupressure: 5: Yintang
(EX-HN3, centrally), Anmian
(bilaterally), heart 7 (Shenmen,
HT7, bilaterally), spleen 6
(Sanyinjiao, SP6, bilaterally), and
liver 3 (Taichong, LR3, bilaterally).
Stimulating acupressure: 6: Baihui
(DU/GV 20, centrally), conception
vessel 6 (Qihai, CV6, centrally),
large intestine 4 (Hegu, LI14,
bilaterally), stomach 36 (Zusanli,
ST36, bilaterally), spleen 6
(Sanyinjiao, SP6, bilaterally), and
kidney 3 (Taixi, KI3 bilaterally).
NR
Once per day. Participants were
required to stimulate the acupoint
in a circular motion with 3 minutes
for each acupoint.
Training: patients were taught to
self-administer acupressure by a
trained acupressure educator.
6 weeks (42
sessions)
Y.L. Zhao,
2015, China
[29]
Acupuncture
(including
moxibustion)
Acupuncture: 6: Baihui (DU/
GV20), Shenting (GV24), Yintang
(EX-HN3), Shenmen (HT7),
Zusanli (ST36, bilaterally),
Sanyinjiao (SP6, bilaterally), and
Guangyuan (CV4).
Moxibustion: 2: Shenque (CV8)
and Guangyuan (CV4).
De qi
Once per day for 7 days, 30 minutes
each time (acupuncture +
moxibustion).
Needle type (depths of insertion):
stainless steel (GV20 : 0.5–0.8 cun,
GV24 : 0.5–0.8 cun, EX-HN3:
0.5–0.8 cun, HT7: 0.3–0.5 cun,
ST36 :1.2–1.5 cun, SP6: 1.0–1.2 cun,
and CV4: 1.0–1.5 cun).
7 days (7
sessions)
W.R. Tan,
2014, Taiwan
[30]
Self-administered
acupressure
3: Hegu (LI4, bilaterally), Zusanli
(ST36, bilaterally), and Sanyinjiao
(SP6, bilaterally).
Acupressure with essential oils
(group A): essential
oils were used for each acupoint
acupressure every time.
De qi
Daily application (6min) on each
morning at the chosen acupoints,
and each acupoint should be
pressed in rotation for 1minute.
Acupressure skills consist of
pointing, pressing, kneading, and
pushing.
5 months
(around 150
sessions)
S. Bokmand,
2013,
Denmark [19]
Manual
acupuncture
4: Neiguan (HC6, bilaterally), Taixi
(KI3, bilaterally), Sanyinjiao (SP6,
bilaterally), and Taichong (LR3,
bilaterally)
NR
One treatment per week for 15–20
minutes.
Needle
type (depths of insertion): NR (NR).
5 weeks (5
sessions)
Y. Feng, 2011,
China [21]
Manual
acupuncture
9: Baihui (DU/GV 20), Fenglong
(ST 40), Neiguan (PC 6),
Sanyinjiao (SP 6), Sishencong (EX-
HN1), Shenmen (TF 4),
Yinlingquan (SP 9), Xuehai (SP
10), and Yintang (EX-HN3).
NR
Daily treatment for 20–30min.
Needling manipulation performed
by the acupuncturist at the interval
of 5–10 minutes.
Needle
type (depths of insertion): NR (NR).
30 days (30
sessions)
S. David, 2010,
USA [31] Acupuncture NR NR Approximately 20 minutes 10 sessions
NR: not reported.
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Two ongoing or completed registered trials evalauted
QoL, which was measured by the Functional Assessment of
Cancer +erapy-General scale [32] and the Functional
Assessment of Chronic Illness +erapy-Fatigue subscale
[31]. Results for these outcomes have not been reported yet
[31, 32].
3.5.6. Adverse Events. Adverse events or safety related to SAS
were mentioned in three trials [19, 22, 29]. One trial reported
that four women experienced mild and temporary adverse
events, and one woman experienced mild but long-lasting
adverse events in the acupuncture group [19]. Zick et al.
reported that six nonserious cases were related to acupressure
treatment, and all adverse events were mild bruising at
acupressure sites [22]. Another study reported that no adverse
events were found in the acupuncture and control groups, and
no participants dropped out of the study because of adverse
events [29]. Zick et al. reported that one participant dropped
out due to the adverse effects of acupressure: bruising [22]. No
included trials performed causality analysis between the re-
ported adverse events and the intervention.
3.5.7. Satisfaction with Treatment. No included trials re-
ported participants’ satisfaction with treatment.
3.5.8. Cost-Effectiveness. No included trials reported on
costs of SAS.
4. Discussion
+is systematic review included five published studies and
two registered ongoing or completed clinical trials. Results
of the five published studies showed that SAS could poten-
tially relieve cancer-related sleep disturbance and improve
QoL of patients with cancer. However, none of the included
RCTs can be used in the meta-analysis because they utilized
different intervention protocols and measurement instru-
ments (indicating substantial clinical heterogeneity) or be-
cause they did not include the data of their results.
Methodological quality of the included studies was identified
to be suboptimal.+e duration of follow-up was short inmost
of the included studies, and only one study reported a 6-
month follow-up after the completion of acupuncture [31].
Large-scale and well-designed clinical trials with long-term
follow-up are warranted to further explore the effects of SAS
on cancer-related sleep disturbance
One relevant systematic review summarized RCTs on
acupuncture for cancer-related insomnia, and two of its
analyzed trials were included in our systematic review as well
[23]. We excluded electroacupuncture and auricular acu-
puncture studies that were originally included in the review
Table 4: Methodological quality assessment of included trials.
Trials Item 1 Item 2 Item 3 Item 4 Item 5 Item6
Item
7 Item 8
Item
9
Item
10
Item
11
Item
12 Item 13 Total
1
H.T. Hoang,
2019, Vietnam
[32]
Yes Yes Yes∗ No Yes∗ NA NA NA NA Yes NA Yes Unclear 6
2 S.M. Zick,2016, USA [22] Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes 12
3
Y.L. Zhao,
2015, China
[29]
Yes Yes No No Yes Yes Yes No Yes Unsure Yes Yes Unsure 8
4
W.R. Tan,
2014, Taiwan
[30]
Yes No Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes 11
5
S. Bokmand,
2013, Denmark
[19]
Yes Yes Yes∗∗ Yes∗∗ Yes∗∗ Yes Yes Yes Yes No Yes Yes Unsure 11
6 Y. Feng, 2011,China [21] Yes Unsure Unsure Unsure Unsure Yes Yes Unsure Yes Unsure Unsure Yes Unsure 5
7 S. David, 2010,USA [31] Unsure Unsure No No No NA NA NA NA Unsure NA Yes Unsure 1
Item 1. “Was the method of randomization adequate?” Item 2. “Was the treatment allocation concealed?” Item 3. “Was the patient blinded to the in-
tervention?” Item 4. “Was the care provider blinded to the intervention?” Item 5. “Was the outcome assessor blinded to the intervention?” Item 6. “Was the
drop-out rate described and acceptable?” Item 7. “Were all randomized participants analyzed in the group to which they were allocated?” Item 8. “Are reports
of the study free of suggestion of selective outcome reporting?” Item 9. “Were the groups similar at baseline regarding the most important prognostic
indicators?” Item 10 “Were cointerventions avoided or similar?” Item 11 “Was the compliance acceptable in all groups?” Item 12 “Was the timing of the
outcome assessment similar in all groups?” Item 13. “Are other sources of potential bias unlikely?—Source: A. D. Furlan, A. Malmivaara, R. Chou, C. G.
Maher, R. A. Deyo, M. Schoene, . . . M. W. Van Tulder (2015). 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group.
Spine, 40(21), 1660-1673. NA: not applicable due to the nature of registered ongoing/completed trials without publishing the final results. ∗+e trial
investigator stated that a partial blinding design was utilized for participants in the true and sham acupressure groups. Partial blinding design was also used for
the true and sham intervention groups given the outcome assessors were the study participants themselves. ∗∗+e clinical study authors stated that
acupuncture group and sham acupuncture group were both patient- and investigator-blinded. Subjective symptoms were self-assessed and the outcome
assessors were therefore deemed as the participants themselves.
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by Choi et al. [23], and included acupressure, an important
type of SAS that is frequently used for cancer symptom
management, in this review to comprehensively explore the
current evidence on SAS for managing cancer-related sleep
disturbance. +e prior published review concluded that, on
the basis of a low level of evidence, acupuncture might be
more effective in reducing cancer-related insomnia than
sham acupuncture, conventional medications, or hormone
therapy [23]. Another relevant systematic review included 41
publications, three of which were related to acupuncture for
cancer-related sleep disturbance, exhibited a high risk of
bias, and reported positive outcomes [33]. +e current re-
view is consistent with previous reviews, indicating that SAS
may be a useful approach to relieving cancer-related sleep
disturbance. Nevertheless, recommending SAS for the
management of sleep disturbance in patients with cancer
may be premature due to the inconclusive evidence identifed
through current literature.
By reviewing the RCTs included in this systematic review,
we found that the SAS intervention protocols, including the
selected acupoints, number of treatment sessions, duration of
stimulation, and type of stimulation, varied significantly
across studies. For instance, although some acupoints, such as
Sanyinjiao (SP6), Yintang (EX-HN3), and Baihui (DU/
GV20), were frequently used in several included studies, none
of the included trials employed a standardized acupoint
formula that higlights the main acupoints for managing
cancer-related sleep disturbance. Manual acupuncture was
typically 15–30min in duration and was conducted once a
day or once a week for a period of 1–5 weeks, whereas self-
administered acupressure was typically conducted for
1–3min per point once a day for a period of 1-5 months.
However, none of the included studies investigated the
“dosage effects” of the SAS intervention protocols, such as the
effects of variations in the acupoint formula, intervention
duration and frequency, on sleep quality in cancer patients.
Four trials compared true SAS interventions with sham
(placebo) interventions [19, 30–32]. Two studies described
the design of sham acupuncture or sham acupressure, and a
similar approach was used for sham SAS which selected
several nonacupoints in the same region as the true acu-
points used in the intervention group [19, 30, 32]. Only one
study highlighted that the selected sham acupoints were
located away from meridians [19]. +e sleep quality of
participants in the true SAS intervention group significantly
improved compared with that in the sham SAS group
[19, 30] which supports the specific treatment effects of SAS.
A further comparison between the sham SAS and no in-
tervention was performed in only one study [19] which
concluded no between-group difference. It was difficult to
identify the size of the SAS placebo effects from the included
studies given that only one small scale study reported sta-
tistical comparisons between the sham SAS and no treat-
ment [19].
No serious adverse events were found in the included
trials. SAS-related adverse events were mentioned in three
trials, and all adverse effects were deemed to be mild
[19, 22, 29]. Based on the limited information regarding the
safety of SAS in the included studies, SAS could be used as a
safe intervention for cancer symptom management with
only mild adverse events occasionally reported. Some of the
adverse events, such as mild bruising, can be effectively
managed and prevented once proper SAS training and
precautions are provided. SAS should be performed or
taught only by a well-trained and qualified therapist, acu-
puncturist, or TCM practitioner. It should be noted that
none of the included trials assessed the causality between the
reported adverse events and the SAS, and some potential
adverse events might be underreported given that most of
the included studies recruited only a small number of
participants.
5. Quality of the Evidence
Limited information can be used to assess the methodo-
logical quality of ongoing or completed registered trials
[31, 32]. A successful design and implementation of blinding
in SAS trials has been significantly challenging given that the
treatment and control procedures are conspicuously dif-
ferent in nature. Considering that some outcomes, such as
sleep parameters in a sleep diary and patient-reported
questionnaires, were completed by the participants them-
selves, reporting bias is possible in the included studies. +e
long-term effects of SAS on cancer-related sleep disturbance
have not been investigated. In addition, the sample sizes of
the included trials are small and the effects of SAS may thus
have been underestimated.
6. Implications for Further Research
and Practice
+e beneficial role of SAS in managing cancer-related sleep
disturbance is promising; however, the evidence remains
inconclusive given the limited quantity and quality of the
included trials as well as the small sample size identifed in
some of the trials. Two included studies primarily focused on
the effects of SAS on cancer-related fatigue while sleep
disturbance was only included as a secondary outcome
[22, 30]. Clinical trials with large sample sizes and robust
methodology are warranted in future research to further
explore the effects of SAS on cancer-related sleep distur-
bance. Identifying the types of SAS and acupoint formula
that work best for cancer-related sleep disturbance and the
optimal SAS intervention frequency and duration are the key
to develop an evidence-based SAS intervention protocol for
managing cancer-related sleep disturbance.
Only four of the included studies used sham SAS as a
comparative treatment, wherein some nonacupoints in the
same region as the true acupoints used in the study inter-
vention were selected [19, 30–32]. However, some of the
nonacupoints might be located near the meridians, which
might further generate some unwanted specific treatment
effects on sleep problems and further undermine the cau-
sality assessment between the ture SAS and patient sleep
outcomes. Appropriate sham SAS design is recommended in
future research to distinguish the specific therapeutic effects
of SAS from its non-specific placebo effects [34]. Locations
of the selected nonacupoints in the sham SAS group should
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be away from meridians to avoid triggering specific treat-
ment effects of acupoint stimulation. Future studies should
also include a long-term follow-up to evaluate the long-term
effects and safety of using SAS for cancer-related sleep
disturbance management. Causality analysis should be
performed between the reported adverse events and the
intervention. SAS should be performed and taught only by
well-trained practitioners to minimize potential adverse
effects and unsafe practice.
7. Conclusion
+is systematic review showed that SAS is a useful approach
to relieving cancer-related sleep disturbance. However, re-
search evidence on SAS for managing cancer-related sleep
disturbance has not been fully conclusive due to the limited
number of existing clinical studies with relatively small
sample size and suboptimal methodological quality. Clinical
trials with large sample size and robust methodology are
warranted in future research.
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